共 16 条
[1]
The lack of functional p21WAF1/CIP1 gene ameliorates progression to chronic renal failure. Megyesi J,Price PM,Tamayo E et al. Proceedings of the National Academy of Sciences of the United States of America . 1999
[2]
Suppression of experimental glomerulonephritis by antiserum against transforming growth factorβ1. Border WA,Okuds S,Languino LR et al. Nature . 1990
[3]
The transcriptional program in the response of human fibroblasts of serum. Iyer VR,Eisen MB,Ross DT et al. Science . 1999
[4]
Regulation of connective tissue growth factor activity in clutured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. Riser BL,Denichilo M,Cortes P et al. Journal of the American Society of Nephrology . 2000
[5]
Effect of chronic therapy with proteolytic enzymes on hypertension-induced renal injury in the rat model of Goldblatt hypertension. Sebekova K,Dammrich J,Fierlbeck W et al. American Journal of Nephrology . 1998
[6]
The cyclin kinase inhibitor p21CIP/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kim YG,Alpers CE,Brugarolas J et al. Kidney International . 1999
[7]
Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Esposito C,He C-J,Striker GE et al. American Journal of Pathology . 1999
[8]
Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. Remuzzi G,Zoja C,Gagliardini E et al. Journal of the American Society of Nephrology . 1999
[9]
Additive effects of enalapril and losartan in(mREN-2)27 transgenic rats. Richer C,Bruneval P,Menard J et al. Journal of Hypertension . 1998
[10]
VEGF(165)mediates glomerular endothelial repair. Ostendorf T,Kunter U,Eitner F et al. The Journal of Clinical Investigation . 1999